1. Home
  2. NBHC vs IOVA Comparison

NBHC vs IOVA Comparison

Compare NBHC & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NBHC

National Bank Holdings Corporation

HOLD

Current Price

$44.04

Market Cap

1.8B

Sector

Finance

ML Signal

HOLD

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$4.20

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NBHC
IOVA
Founded
2009
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.7B
IPO Year
2011
2008

Fundamental Metrics

Financial Performance
Metric
NBHC
IOVA
Price
$44.04
$4.20
Analyst Decision
Buy
Buy
Analyst Count
3
10
Target Price
$47.67
$9.00
AVG Volume (30 Days)
433.0K
14.1M
Earning Date
04-21-2026
05-07-2026
Dividend Yield
3.03%
N/A
EPS Growth
N/A
14.84
EPS
0.46
N/A
Revenue
$47,100,000.00
N/A
Revenue This Year
$39.96
$47.74
Revenue Next Year
$7.14
$40.31
P/E Ratio
$96.76
N/A
Revenue Growth
2.86
N/A
52 Week Low
$35.06
$1.70
52 Week High
$45.63
$5.63

Technical Indicators

Market Signals
Indicator
NBHC
IOVA
Relative Strength Index (RSI) 59.16 56.87
Support Level $40.68 $2.07
Resistance Level N/A $4.35
Average True Range (ATR) 0.98 0.33
MACD 0.13 -0.00
Stochastic Oscillator 72.88 55.29

Price Performance

Historical Comparison
NBHC
IOVA

About NBHC National Bank Holdings Corporation

National Bank Holdings Corp offers a full range of banking products and financial services to commercial, business, and consumer clients predominantly in Colorado, with a focus on personalized service through relationship managers and banking center associates. The company provides commercial and industrial loans, non-owner occupied commercial real estate loans, Small Business Administration loans as a Preferred Lender Provider, U.S. Department of Agriculture and Farm Service Agency loans, commercial deposit and treasury management products, business online and mobile banking, consumer and residential real estate loans, deposit services, and trust and wealth management services. Its services emphasize full-relationship banking, integrating lending, deposits, and cash management solutions.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.

Share on Social Networks: